Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

FABRY DISEASE REGISTRY

I'm Interested!

The Rare Disease Registry Program (including but not limited to, Gaucher, Fabry, MPS I, and Pompe diseases) is a multi-center, international, longitudinal, observational program that tracks the natural history and outcomes of patients with these rare diseases.

  • Sex at Birth: Any
  • Age: Child (Birth - 17), Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Registry
  • Trial Phase: NA
  • Conditions Being Studied: Fabry Disease

Study Purpose

Fabry disease is a rare X-linked lysosomal storage disorder that results from mutations in the gene encoding the lysosomal hydrolase, a-galactosidase A (aGAL). This is a research study that collects medical information on people with Fabry disease around the world.

Principal Investigator
Laura Konczal MD
Department/Division
General (Genetics)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

  • UH IRB: STUDY20200704
  • StudyID: 2021-0538
  • ClinicalTrials.gov: NCT00196742
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422